
COVID-19 Vaccine Developers Want to Keep Getting Billions in Public Money With No Strings Attached
Drug companies have received over $10 billion from the US government for COVID-19 vaccine production. Yet those companies weren’t required to offer their vaccines at fair prices or share intellectual property rights — and they want to keep it that way.